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Figure 1. Diagrammatic representation of TCR signalling pathways measured by mass cytometry panel. Cartoon depicts the TCR-related signalling
pathways examined in this study in our minimal stimulation system wherein T cells present antigen to each other. Solid lines indicate evidence of direct
and dotted lines suggested or indirect interaction. Signalling proteins and post-translational modifications directly measured by mass cytometry
antibodies are coloured blue (proteins) or green/red (sites of phosphorylation events) and outlined in purple. The mass cytometry panel also profiled
surface proteins TCRb, CD8a, CD45, CD25 (IL2Ra), and CD44.
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Figure 2. Mass cytometry measurements of signalling in singlet and doublet events. (a) Naı̈ve CD8+ T cells were stimulated with 1 mM peptides of
various potencies for 0, 1, 2, 4 and 6 hr before profiling by mass cytometry. Histograms depict pS6 signal. (b) Bubble plots of all signalling molecules
after stimulation as in (a) in mass cytometry events with 1 or 2 cell-equivalents of DNA (singlets or doublets, respectively). The size of the bubbles
denotes the percentage of positive cells, and the colour denotes the centred and scaled median intensity of each positive fraction. Results are
representative of cells from six biological replicates measured in two independent experiments as detailed in Supplementary file 1.
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Figure 2—figure supplement 1. Titrating peptide concentration. (a) Flow cytometry measurements of pS6 and pERK after 2 or 4 hr of simulation with
10 nM, 100 nM or 1 mM of N4, T4, G4 or NP68 peptides. Results are representative of 3 biological replicates.
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Figure 2—figure supplement 2. Gating based on DNA content and comparison of signalling markers. (a) Gating strategy used to select mass
cytometry events containing one or two cell-equivalents of DNA from mass cytometry data in Figure 2. (b) Percentages of mass cytometry events
deemed doublets (2 cell-equivalents of DNA). Plot depicts mean and standard deviation of 6 biological replicates measured in two independent
Figure 2—figure supplement 2 continued on next page
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Figure 2—figure supplement 2 continued
experiments as detailed in Supplementary file 1. (c–d) Expression of total (c) and phosphorylated (d) protein measurements in cells stimulated with N4
peptide for 1 hr, gated on singlets (red) versus doublets (blue). Data are representative of 6 biological replicates measured in two independent
experiments. (e) As (d) after normalization of signalling molecules to total DNA levels.
Ma et al. eLife 2020;9:e53948. DOI: https://doi.org/10.7554/eLife.53948 6 of 23
Research article Computational and Systems Biology Immunology and Inflammation
pERK1/2 pAKT
IκBα pS6
A
pS6 PE
DMSO
MEK 0.5 μM
MEK 1μM
MEK 5μM
Rapa 200nM
R + M 0.5μM
R + M 1μM
R + M 5μM
NP68 + DMSO
N4
B
pS6 PE
p
E
R
K
1
/2
 A
F
4
8
8
DMSO MEK 0.5μM MEK 1μM MEK 5μM
Rapamycin R + M 0.5μM R + M 1μM R + M 5μM
N4
NP68
N4
NP68
C D
R
ap
a 
20
nM
R
ap
a 
20
0n
M
R
ap
a 
2µ
M
M
E
K
 0
.5
µM
M
E
K
 1
µM
0.0
0.2
0.4
0.6
0.8
1.0
 I
n
h
ib
it
o
r 
p
S
6
+
 /
 
D
M
S
O
 c
tr
l 
p
S
6
+
D
M
S
O
R
ap
a 
20
nM
R
ap
a 
20
0n
M
R
ap
a 
2µ
M
M
E
K
 0
.5
µM
M
E
K
 1
µM
100
1000
10000
p
S
6
 M
F
I
0h 1h 2h 4h 6h
0
20
40
60
%
 P
o
s
it
iv
e
0h 1h 2h 4h 6h
0
5
10
15
20
25
0h 1h 2h 4h 6h
0
20
40
60
80
100
%
 P
o
s
it
iv
e
0h 1h 2h 4h 6h
-20
0
20
40
60
80
100
N4
T4
G4
NP68
Figure 3. Kinetics of selected signalling proteins and impact of MEK and mTOR pathway inhibitors on T cell activation parameters. (a) The percentage
of cells positive for each marker is plotted against time. Results depict combined data from six biological replicates measured in two independent
experiments as detailed in Supplementary file 1. Points represent the mean and error bars depict the SD. Data underlying plots are provided in
Supplementary file 5. (b–c) Flow cytometry measurements of pS6[S235/236] and pERK1/2 after 2 hr of pre-treatment with DMSO vehicle control,
rapamycin (Rapa) 200 nM, MEK162 (MEK) 0.5 mM, 1 mM and 5 mM, or combined rapamycin with MEK162 (R + M), followed by 4 hr stimulation with 1 mM
N4 or NP68 peptides. Results are representative of 3 independent experiments. (d) The fraction of pS6+ cells in N4-stimulated conditions with the
indicated inhibitor treatments versus DMSO (top). The median fluorescent intensity of pS6 among pS6+ cells in N4-stimulated conditions with the
indicated inhibitor treatments (bottom). Lines represent the median. Results depict combined data from three independent experiments.
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Figure 3—figure supplement 1. Kinetics of total protein levels and surface markers. The median intensity of proteins measured by mass cytometry
under stimulation with ligands of various potencies over time. Points represent the mean and error bars depict the SD. Results depict combined data
from six biological replicates measured in two independent experiments as detailed in Supplementary file 1.
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Figure 3—figure supplement 2. Kinetics of pSTAT5, pLCK and pSLP76 signalling proteins and testing the impact of IL2. (a) As Figure 3a for pSTAT5,
pLCK and pSLP76. Plots depict combined data from six biological replicates measured in two independent experiments as detailed in
Supplementary file 1. Points represent the mean and error bars depict the SD. Data underlying plots are provided in Supplementary file 1. (b) Flow
cytometry measurements of pSTAT5, pS6[S235/236] pERK1/2, pAKT and IkBa, stimulated with peptides of various potencies for 4 hr, in the presence or
absence of IL2. Results depict combined data from three biological replicates measured in 2–3 independent experiments. Bar charts represent the
mean and error bars depict the SD.
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Figure 3—figure supplement 3. pERK and pS6 distributions and additional MEK and mTOR inhibition data. (a) Cells were gated on pERK1/2 positive
and negative populations. Within these populations, the median marker intensity was calculated at each timepoint in each condition. (b) As (a) for pS6
[S235/S236]. (c) As (b) after normalization of pS6 intensity to total S6 intensity within each cell. (a–c) Plots are representative of 6 biological replicates
measured in two independent experiments as detailed in Supplementary file 1. (d) As Figure 3b, measuring pERK1/2. (e) Flow cytometry
measurements of pS6[S235/236] after stimulation in the presence of the indicated concentrations of rapamycin. (f) The median fluorescent intensity of
CD44 among live cells in N4-stimulated conditions with the indicated inhibitor treatments. Results depict combined data from three independent
experiments. Lines represent the mean. (g) 2 day proliferation assay of cells treated as in (d–f) measured using Cell Proliferation Dye eFluor450. (d,e,g)
Results are representative of 3 biological replicates from 2 to 3 independent experiments.
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Figure 4. Examination of multi-dimensional phenotypes in mass cytometry signalling data. (a) Mass cytometry stimulation time courses were further
investigated for multidimensional phenotypes that changed in abundance with stimulation. Analysis was run on two multiplexed biological replicates as
Figure 4 continued on next page
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Figure 4 continued
described in Materials and methods. Phenotypic hyperspheres were defined within the multidimensional mass cytometry space and abundances of cells
from each condition enumerated within each hypersphere. Each column in the heatmap represents an individual hypersphere. At the top of the
heatmap, rows correspond to mass cytometry marker measurements with colour depicting the intensity of each marker in each hypersphere. Clustering
by Pearson correlation was performed on these hypersphere marker intensity measurements. At the bottom of the heatmap, rows correspond to
stimulation conditions with colour depicting the binned log2-fold change in cellular abundance in stimulated versus unstimulated conditions within each
hypersphere. ns = hyperspheres that did not significantly change in abundance. Phenotypic clusters of interest, A, A’, B, B’, are indicated in both CD44+
and CD44- populations by coloured highlighting of the dendrogram. Statistics underlying the heatmap are provided in Supplementary file 5. (b)
Percentages of cells exhibiting A, A’, B, and B’ phenotypes in mass cytometry measurements. Results are combined data from six biological replicates
measured in two independent experiments as detailed in Supplementary file 1. Points represent the mean and error bars depict the SD. Data
underlying plots are provided in Supplementary file 5. (c) Phenotypes as in (b) further sub-divided by CD44 expression.
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Figure 4—figure supplement 1. t-SNE visualization of significantly differentially abundant hyperspheres. a) tSNE plots depict hyperspheres from
Figure 4a. Colour indicates log2-fold change of cellular abundance in each stimulated condition versus unstimulated for each hypersphere. (b) As (a)
with colour indicating the median intensity of each marker within each hypersphere. Underlying data are provided in Supplementary file 5.
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Figure 4—figure supplement 2. Heatmap of populations in Figure 4c including pS6-. Data from Figure 4c, additionally including pS6- phenotypes,
are plotted as a heatmap. Plots depict averages from six biological replicates measured in two independent experiments as detailed in
Supplementary file 1.
Ma et al. eLife 2020;9:e53948. DOI: https://doi.org/10.7554/eLife.53948 15 of 23
Research article Computational and Systems Biology Immunology and Inflammation
pS6+pSTAT5+pERK+
pS6+pERK+
pS6+pSTAT5+pERK+
pS6+pERK+
pS6+pSTAT5+pERK+
pS6+pERK+
pS6+pSTAT5+pERK+
pS6+pERK+
pS6+pSTAT5+pERK+
pS6+ pSTAT5+
pS6+
pS6+ pSTAT5+
pS6+ pSTAT5+
pS6+
pS6+ pSTAT5+
pS6+ pSTAT5+
pS6+
pS6+pSTAT5+pERK+
pS6+ pSTAT5+
N4
T4
G4
1h 2h 4h 6h
L
ig
a
n
d
 P
o
te
n
c
y
Figure 5. Cartoon Model. Cartoon depicts the kinetics of the four main signalling phenotypes in cells stimulated with ligands of varying potencies (N4,
T4, G4) over time from data in Figures 3a and 4 (note the transient pERK+ populations, even with G4). Black outlines indicate CD44+ populations.
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Figure 5—figure supplement 1. Activation trajectories for examining the order of signalling events. (a) Mass cytometry data were grouped by
biological replicate and stimulating ligand before constructing activation trajectories by ordering the cells according to pS6 intensity. Plots depict 1000
Figure 5—figure supplement 1 continued on next page
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Figure 5—figure supplement 1 continued
randomly sampled cells from an example replicate. Colours represent real times at which cells were sampled. (b) Example of pERK1/2 intensity
measurements along the trajectories constructed in (a). (c) Loess curves were fitted to intensities of the indicated markers along the trajectories
depicted in (a). Dotted lines represent the estimated standard error from the loess fits. (d) As (c) for additional signalling markers. Trajectories are
representative of the four biological replicates that included at least three time points, measured in two independent experiments as detailed in
Supplementary file 1.
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Figure 6. Simultaneous measurement of phosphorylation of S6 and mRNA expression of transcription factors Nr4a1 and Irf8. (a) Combined
phosphoflow cytometry of pS6 and RNA flow cytometry of Nr4a1 and Irf8 transcripts in naı̈ve OT-I CD8+ T cells stimulated with N4, T4, G4 or NP68
peptides for 2 hr, gated on single live cells in which the control gene Rpl39 was detected. (b) Frequency of phenotypes depicted in (a) after stimulation
for 1, 2, 4 or 6 hr. Data are representative of 3 independent experiments.
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Figure 6—figure supplement 1. RNA flow cytometry gating strategy and histograms. (a) Single cell RNA-seq of Irf8 and Nr4a1 expression after 0–6 hr
stimulation with 1 mM N4 peptide from previously published data (Richard et al., 2018), ArrayExpress E-MTAB-6051, depicted as violin plots, with dots
Figure 6—figure supplement 1 continued on next page
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Figure 6—figure supplement 1 continued
indicating individual cells. (b) Gating strategy for combined phosphoflow cytometry of pS6 and RNA flow cytometry: cells were gated on size, single
cells, live cells and Rpl39+ cells, before examining Nr4a1, Irf8 and pS6 with gates based on fluorescence-minus-one stains. (c) As Figure 6, histograms
depict flow cytometry measurements of Nr4a1, Irf8 and pS6 (gated on Rpl39+ cells), and the control mRNA Rpl39 (gated on live cells) over all time
points measured. Data are representative of 3 independent experiments.
Ma et al. eLife 2020;9:e53948. DOI: https://doi.org/10.7554/eLife.53948 21 of 23
Research article Computational and Systems Biology Immunology and Inflammation
1h 2h 4h 6h
0
5
10
15
20
25
1h 2h 4h 6h
0
5
10
15
20
25
1h 2h 4h 6h
0
20
40
60
80
%
 P
o
s
it
iv
e
1h 2h 4h 6h
0
20
40
60
80
1h 2h 4h 6h
0
20
40
60
80
N4
T4
G4
NP68
1h 2h 4h 6h
0
5
10
15
20
25
%
 P
o
s
it
iv
e
A pERK AF350 pSLP76 PE pZAP70 PECy7
pS6 V450 pSTAT5 AF488 CD44 BV711
N4 T4 G4 NP68
1h
6h
B
Ligand Potency
pS6 V450
p
E
R
K
 A
F
3
5
0
Figure 7. Signalling phenotypes in T cells stimulated with peptide-pulsed APCs. (a) Naı̈ve CD8+ T cells were stimulated with mature BMDCs loaded
with peptides of various potencies for 1, 2, 4 and 6 hr before profiling by flow cytometry. The percentage of cells positive for each marker is plotted
against time. Results depict combined data from three independent experiments. Points represent the mean and error bars depict the SD. (b) Example
flow cytometry data from (a) of pERK1/2 and pS6 measured at 1 and 6 hr.
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Figure 7—figure supplement 1. Expression of adhesion and costimulatory molecules on T cells and BMDCs. (a) Expression of CD80 and ICAM-1 on T
cells after 6 hr of stimulation with 1 mM of the indicated peptides. Results are representative of 3 biological replicates measured in two independent
experiments. (b) Surface protein phenotyping of BMDCs before and after maturation for 1 day with LPS. Results are representative of 5 independent
experiments.
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